These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
188 related items for PubMed ID: 37405567
1. In-depth urinary and exosome proteome profiling analysis identifies novel biomarkers for diabetic kidney disease. Du S, Zhai L, Ye S, Wang L, Liu M, Tan M. Sci China Life Sci; 2023 Nov; 66(11):2587-2603. PubMed ID: 37405567 [Abstract] [Full Text] [Related]
2. Clinical significance of UbA52 level in the urine of patients with type 2 diabetes mellitus and diabetic kidney disease. Xu X, Dong Y, Liu M, Li Y, Zhang Y. Nefrologia (Engl Ed); 2021 Nov; 41(5):548-555. PubMed ID: 36165137 [Abstract] [Full Text] [Related]
3. Uromodulin mRNA from Urinary Extracellular Vesicles Correlate to Kidney Function Decline in Type 2 Diabetes Mellitus. Yamamoto CM, Murakami T, Oakes ML, Mitsuhashi M, Kelly C, Henry RR, Sharma K. Am J Nephrol; 2018 Nov; 47(5):283-291. PubMed ID: 29779026 [Abstract] [Full Text] [Related]
4. Expression of urinary exosomal miRNA-615-3p and miRNA-3147 in diabetic kidney disease and their association with inflammation and fibrosis. Wang J, Tao Y, Zhao F, Liu T, Shen X, Zhou L. Ren Fail; 2023 Dec; 45(1):2121929. PubMed ID: 36695327 [Abstract] [Full Text] [Related]
5. Urinary exosomal microRNA panel unravels novel biomarkers for diagnosis of type 2 diabetic kidney disease. Eissa S, Matboli M, Aboushahba R, Bekhet MM, Soliman Y. J Diabetes Complications; 2016 Dec; 30(8):1585-1592. PubMed ID: 27475263 [Abstract] [Full Text] [Related]
6. Urinary proteins detected using modern proteomics intervene in early type 2 diabetic kidney disease - a pilot study. Golea-Secara A, Munteanu C, Sarbu M, Cretu OM, Velciov S, Vlad A, Bob F, Gadalean F, Gluhovschi C, Milas O, Simulescu A, Mogos-Stefan M, Patruica M, Petrica L, Zamfir AD. Biomark Med; 2020 Nov; 14(16):1521-1536. PubMed ID: 33090017 [Abstract] [Full Text] [Related]
7. Urinary Exosomal MiRNA-4534 as a Novel Diagnostic Biomarker for Diabetic Kidney Disease. Zhao Y, Shen A, Guo F, Song Y, Jing N, Ding X, Pan M, Zhang H, Wang J, Wu L, Ma X, Feng L, Qin G. Front Endocrinol (Lausanne); 2020 Nov; 11():590. PubMed ID: 32982978 [Abstract] [Full Text] [Related]
8. Combined detection of urinary biomarkers noninvasively predicts extent of renal injury in patients with early diabetic kidney disease with kidney qi deficiency syndrome: A retrospective investigation. Wu W, Meng XJ, Wan BY, Fang QJ, Liu YL, Wang J, Fu Y, Yuan CC, Wang MZ, Chong FL, Wan YG, Shen SM. Anat Rec (Hoboken); 2023 Dec; 306(12):2945-2957. PubMed ID: 34910381 [Abstract] [Full Text] [Related]
9. Screening candidate diagnostic biomarkers for diabetic kidney disease. Huang X, Zhang H, Liu J, Yang X, Liu Z. J Clin Lab Anal; 2024 Feb; 38(3):e25000. PubMed ID: 38299750 [Abstract] [Full Text] [Related]
10. Changes in urine proteome accompanying diabetic nephropathy progression. Lewandowicz A, Bakun M, Kohutnicki R, Fabijańska A, Kistowski M, Imiela J, Dadlez M. Pol Arch Med Wewn; 2015 Feb; 125(1-2):27-38. PubMed ID: 25578432 [Abstract] [Full Text] [Related]
11. Serum integrative omics reveals the landscape of human diabetic kidney disease. Liu S, Gui Y, Wang MS, Zhang L, Xu T, Pan Y, Zhang K, Yu Y, Xiao L, Qiao Y, Bonin C, Hargis G, Huan T, Yu Y, Tao J, Zhang R, Kreutzer DL, Zhou Y, Tian XJ, Wang Y, Fu H, An X, Liu S, Zhou D. Mol Metab; 2021 Dec; 54():101367. PubMed ID: 34737094 [Abstract] [Full Text] [Related]
13. In-depth profiling of urinary N-glycome in diabetic kidney disease by ultrafast glycoprotein immobilization for glycan extraction (UltraGIG). Cai Y, Ren W, Wang H, Bian Q. Anal Chim Acta; 2022 Aug 15; 1221():340144. PubMed ID: 35934376 [Abstract] [Full Text] [Related]
14. Identification of a Non-Invasive Urinary Exosomal Biomarker for Diabetic Nephropathy Using Data-Independent Acquisition Proteomics. Ding X, Zhang D, Ren Q, Hu Y, Wang J, Hao J, Wang H, Zhao X, Wang X, Song C, Du J, Yang F, Zhu H. Int J Mol Sci; 2023 Sep 01; 24(17):. PubMed ID: 37686366 [Abstract] [Full Text] [Related]
15. [Research status and prospect of novel biomarkers for diabetic kidney disease]. Feng ST, Wang B, Liu BC. Zhonghua Yi Xue Za Zhi; 2021 Mar 16; 101(10):691-694. PubMed ID: 33721945 [Abstract] [Full Text] [Related]
16. Real-World Diagnosis and Treatment of Diabetic Kidney Disease. Rodriguez F, Lee DJ, Gad SS, Santos MP, Beetel RJ, Vasey J, Bailey RA, Patel A, Blais J, Weir MR, Dash R. Adv Ther; 2021 Aug 16; 38(8):4425-4441. PubMed ID: 34254257 [Abstract] [Full Text] [Related]
17. Diabetic nephropathy induces changes in the proteome of human urinary exosomes as revealed by label-free comparative analysis. Zubiri I, Posada-Ayala M, Sanz-Maroto A, Calvo E, Martin-Lorenzo M, Gonzalez-Calero L, de la Cuesta F, Lopez JA, Fernandez-Fernandez B, Ortiz A, Vivanco F, Alvarez-Llamas G. J Proteomics; 2014 Jan 16; 96():92-102. PubMed ID: 24211404 [Abstract] [Full Text] [Related]
18. Prognostic imaging biomarkers for diabetic kidney disease (iBEAt): study protocol. Gooding KM, Lienczewski C, Papale M, Koivuviita N, Maziarz M, Dutius Andersson AM, Sharma K, Pontrelli P, Garcia Hernandez A, Bailey J, Tobin K, Saunavaara V, Zetterqvist A, Shelley D, Teh I, Ball C, Puppala S, Ibberson M, Karihaloo A, Metsärinne K, Banks RE, Gilmour PS, Mansfield M, Gilchrist M, de Zeeuw D, Heerspink HJL, Nuutila P, Kretzler M, Welberry Smith M, Gesualdo L, Andress D, Grenier N, Shore AC, Gomez MF, Sourbron S, BEAt-DKD consortium. BMC Nephrol; 2020 Jun 29; 21(1):242. PubMed ID: 32600374 [Abstract] [Full Text] [Related]
19. Proteomic profiling and correlations with clinical features reveal biomarkers indicative of diabetic retinopathy with diabetic kidney disease. Fan X, Xu M, Chen X, Ren Q, Fan Y, Wang R, Chen J, Cui L, Wang Z, Sun X, Guo N. Front Endocrinol (Lausanne); 2022 Jun 29; 13():1001391. PubMed ID: 36277688 [Abstract] [Full Text] [Related]